Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Radiotherapy Center Cluj S.R.L.

Verified siteinfo

Romania Strada Oitelor Nr 7, 040278 Bucharest, Romania

  • Non-small cell lung cancer · Gastrooesophageal cancer · Oesophageal adenocarcinoma stage II
  • Adult patients

About Specializations

Radiotherapy Center Cluj S.R.L. in Bucharest, Romania specialises in clinical trials of conditions such as Non-small cell lung cancer, Gastrooesophageal cancer, Oesophageal adenocarcinoma stage II, Oesophageal adenocarcinoma stage III, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms (Oncology)

The Radiotherapy Center Cluj S.R.L. focuses on clinical research in cancer, aiming to evaluate innovative treatments and improve patient outcomes.

  • High-Risk Metastatic Hormone-Sensitive Prostate Cancer
  • Previously Untreated MET Amplified Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
  • Subjects with High Risk Invasive Urothelial Carcinoma
  • Subjects with Resected Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus or Gastroesophageal Junction

With four active trials and a dedicated team of four investigators, the site is testing targeted antibodies, CDK4/6 inhibition, and immunotherapy to enhance survival and disease‑free outcomes for patients across these tumor types.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Oitelor Nr 7040278 BucharestRomania
Open in maps ↗
Recruiting now
no trials
Conditions studied
8
Partner status
Verified site

More sites in BucharestRomania

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Gastrooesophageal cancer+5

Not recruiting

Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol Myers Squibb International Corporation

Non-small cell lung cancer

Not recruiting

Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Transitional cell carcinoma

Not recruiting

Study Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Non-small cell lung cancer

Not recruiting

Study of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Telisotuzumab Vedotin
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.